SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-24-000008
Filing Date
2024-01-31
Accepted
2024-01-31 07:44:38
Documents
3
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 6-K a240131nisar-6k.htm 6-K 17241
2 ANNUAL REPORT 2023 a240131-99_1.pdf EX-99 4298691
3 NOVARTIS IN SOCIETY - INTEGRATED REPORT 2023 a240131-99_2.pdf EX-99 4372120
  Complete submission text file 0001370368-24-000008.txt   11961047
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 24580649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)